IP Library Granted Patent US 7,655,434
Granted Patent B2
US 7,655,434 · App. 11/052,001 · Granted Feb 2, 2010

Live-cell biosensor polypeptides and methods of use

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,434
App. No.
11/052,001
Granted
Feb 2, 2010
Kind
B2
Abstract

Methods and compositions for determining the duration of a cell cycle phase of a mammalian cell, as well as identification of the cell cycle stage of fixed mammalian cells, are provided. In practicing the subject methods, at least one biosensor polypeptide that monitors a cell-cycle phase in a mammalian cell, such as mitosis, G1, S, or G2 phase, is used to determine the duration of a cell-cycle phase of a mammalian cell. Also provided are methods for identifying an agent (e.g., a gene product or small molecule compound) that modulates the duration of a cell-cycle phase of a mammalian cell, as well as kits and systems for practicing the subject methods.

Claims (41)

1. A method of monitoring a cell-cycle phase of a mammalian cell, the method comprising:

culturing a mammalian cell comprising

a mitosis biosensor polypeptide (MBP) comprising a plasma membrane targeting domain, a nuclear localization signal and a fluorescent label,

a G1 phase biosensor polypeptide (G1BP) comprising a fluorescent label, and

a S phase biosensor polypeptide (SBP) comprising a fluorescent label,

under conditions suitable for proliferation of the mammalian cell, wherein each of the fluorescent labels of the G1BP, SBP, and MBP emit different fluorescence emission spectra; and

detecting a MBP fluorescence pattern and at least one of

a) G1BP fluorescence pattern established by a nuclear localized fluorescence and a cytoplasmic localized fluorescence; and

b) SBP fluorescence pattern established by formation of fluorescence puncta in a nuclear region of the mammalian cell and disappearance of fluorescence,

wherein nuclear envelope breakdown (NEB) is characterized by MBP fluorescence localized to a plasma membrane, indicating a mitosis phase of the cell cycle, and nuclear envelope reformation (NER) is characterized by MBP fluorescence localized to a nucleus, indicating interphase of the cell cycle.

2. The method according to claim 1 , wherein prior to said detecting the cells are fixed.

3. The method according to claim 1 , wherein a G1BP fluorescence pattern established by nuclear localized fluorescence is indicative of G1 phase of a cell cycle.

4. The method according to claim 1 , wherein a G1BP fluorescence pattern established by cytoplasmic localized fluorescence is indicative of S or G2 phase of a cell cycle.

5. The method according to claim 1 , wherein a SBP fluorescence pattern established by formation of fluorescence puncta in a nuclear region of the mammalian cell is indicative of S phase of a cell cycle.

6. The method according to claim 1 , wherein detection of the MBP fluorescent pattern is by total internal reflection fluorescence (TIRF) microscopy.

7. The method according to claim 1 , wherein cell cycle phase duration is determined in a plurality of cells and in parallel.

8. A method for determining duration of a cell-cycle phase of a mammalian cell, the method comprising:

culturing a mammalian cell comprising

a mitosis biosensor polypeptide (MBP) comprising a plasma membrane targeting domain, a nuclear localization signal and a fluorescent label,

a G1 phase biosensor polypeptide (G1BP) comprising a fluorescent label and

a S phase biosensor polypeptide (SBP) comprising a fluorescent label

under conditions suitable for proliferation of the mammalian cell, wherein each of the fluorescent labels of the G1BP, SBP, and MBP emit different fluorescence emission spectra; and

determining a time interval between at least two of

a) NEB,

b) NER,

c) formation of fluorescence puncta in a nuclear region of the mammalian cell,

d) disappearance of fluorescence puncta in a nuclear region of the mammalian cell,

e) appearance of fluorescence in a nuclear region of the mammalian cell, and

f) translocation of fluorescence from a nuclear region to a cytoplasmic region of the mammalian cell,

wherein a), b), c), d), e), and f) are established by detection of at least one of a MBP fluorescence pattern, a G1BP fluorescence pattern, or a SBP fluorescence pattern

wherein the time interval between NEB and NER is indicative of duration of a mitosis phase of the cell cycle and the time interval between NER and NEB is indicative of duration of interphase of the cell cycle.

9. The method according to claim 8 , further comprising determining a time interval between at least two of NEB, prometaphase, metaphase, anaphase, cytokinesis, and NER, wherein NEB and NER are established by detection of a MBP fluorescence pattern and prometaphase, metaphase, anaphase, cytokinesis are established by detection of a condensed chromatin associated M BP fluorescence pattern.

10. The method according to claim 8 , wherein the time interval is between NER and formation of fluorescence puncta in a nuclear region of the mammalian cell, which time interval is indicative of duration of G1 phase of a cell cycle.

11. The method according to claim 8 , wherein the time interval is between formation of fluorescence puncta in a nuclear region of the mammalian cell and disappearance of fluorescence puncta in the nuclear region of the mammalian cell, which time interval is indicative of duration of S phase of a cell cycle.

12. The method according to claim 8 , wherein the time interval is between disappearance of fluorescence puncta in a nuclear region of the mammalian cell and NEB, which time interval is indicative of duration of G2 phase of a cell cycle.

13. The method according to claim 8 , wherein the time interval is between NER and translocation of fluorescence from a nuclear region to a cytoplasmic region of the mammalian cell, which time interval is indicative of duration of G1 phase of a cell cycle.

14. The method according to claim 8 , wherein the time interval is between translocation of fluorescence from a nuclear region to a cytoplasmic region of the mammalian cell and disappearance of fluorescence puncta in a nuclear region of the mammalian cell, which time interval is indicative of duration of S phase of a cell cycle.

15. The method according to claim 8 , wherein the time interval is between appearance of fluorescence in a nuclear region of the mammalian cell and translocation of fluorescence from a nuclear region to a cytoplasmic region of the mammalian cell, which time interval is indicative of duration of G1 phase of a cell cycle.

16. The method according to claim 8 , wherein detection of the MBP fluorescent pattern is by total internal reflection fluorescence (TIRF) microscopy.

17. The method according to claim 8 , wherein cell cycle phase duration is determined in a plurality of cells and in parallel.

18. The method according to claim 8 , wherein said culturing is performed in the presence of a candidate agent, wherein an increase or decrease in the time interval as compared to a time interval in the absence of a candidate agent indicates the candidate agent modulates duration of a phase of a cell cycle of the mammalian cell.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Nov 4, 2008
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021781/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2005
From: JONES, JOSHUA T.; HAHN, ANGELA TERESA; MEYER, TOBIAS
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 016264/0863 →
Continuity (2)
Provisional Application 6054129700 · Feb 3, 2004
Related Publication 20050233356A1 · Oct 20, 2005